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Abstract
Background The availability of high-end endoscopic
equipment, microcatheters, miniballoons, tiny laser fibers,
and other devices has been instrumental in the development
of minimally invasive fetoscopic interventions. These
interventions are performed for a spectrum of fetal disease
states that progress in severity over the course of gestation
and have a huge impact on termination of pregnancy rates,
fetal demise, perinatal mortality and morbidity, and long-
term prognosis. This report aims to introduce interested
readers to these new procedures.
Methods Fetoscopic interventions such as laser coagula-
tion of pathologic placental vascular connections in twin-
to-twin-transfusion-syndrome, fetal biopsies, fetal tracheal
balloon occlusion in diaphragmatic hernia, perforation of
posterior urethral valves, tracheal decompression in fetal
laryngeal atresia, and even coverage of spina bifida aperta
can be performed by percutaneous minimally invasive
fetoscopic techniques.
Results In contrast to prenatally untreated patients, the
majority of patients who underwent fetoscopic interven-
tions followed by state-of-the-art neonatal intensive care
experienced improved survival rates and enhanced quality
of life. Yet for some patients, significant morbidity from
the underlying disease or fetal surgical complications, most
often early preterm delivery, persist in postnatal life.
Conclusion A growing spectrum of fetal disease states
has become amenable to minimally invasive fetoscopic
interventions. Sufficient training, an interdisciplinary
approach, ethical board supervision, and continued scien-
tific assessment of benefits and risks are important for the
success and acceptance of these procedures. Further
improvements in fetal selection, surgical techniques, and
postnatal management accompanied by the development of
specialized devices are desired.
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Fetal surgery aims to improve the poor prognoses of human
fetuses affected by a spectrum of disease states that pro-
gress in severity over the course of gestation and have a
huge impact on termination of pregnancy rates, fetal
demise, perinatal mortality and morbidity, and long-term
prognosis.
Lacking minimally invasive tools at the time, Michael
Harrison and other investigators introduced open fetal
surgery requiring maternal laparotomy and hysterotomy in
the early 1980s [1]. Until today, the open fetal surgical
approach is performed for some fetal surgical procedures,
most commonly fetal spina bifida repair [2]. To reduce the
maternal trauma from the open fetal surgical approach,
minimally invasive fetoscopic procedures are being
developed.
After fetoscopy first became available in about 1970, its
clinical role for many years remained mostly confined to
diagnostic purposes because image quality, particularly the
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lack of video cameras, put a lid on the development of
more complex orchestrated procedures [3]. Since then, the
availability of high-end endoscopic equipment as well as
microcatheters, miniballoons, tiny laser fibers, and other
devices has prompted the systematic development of
minimally invasive fetoscopic interventions by a small
number of teams around the world. As a consequence,
fetoscopic procedures have become feasible [4–10], as
have laser coagulation of pathologic placental vascular
connections in twin–twin transfusion syndrome, fetoscopic
umbilical cord ligation to prevent neurologic injury or
demise in discordant monochorionic twins or twin-reversed
arterial perfusion (TRAP), fetal tracheal balloon occlusion
in diaphragmatic hernia, fulgurization of posterior urethral
valves, tracheal decompression in fetal laryngeal atresia,
and even coverage of spina bifida aperta over the past one
and a half decades.
Maternal and fetal pain management monitoring
and tocolysis
Infiltration of the maternal abdominal and uterine wall
with local anesthetics provides sufficient maternal anal-
gesia during most single-trocar fetoscopic procedures
such as laser ablation of placental vessels or fetal tra-
cheal balloon occlusion. Intraumbilical or direct fetal
intramuscular administration of opioid analgesics and
muscle relaxants suffices for most invasive procedures
performed on the fetus. Only lengthy and complex pro-
cedures such as fetoscopic surgery for fetal spina bifida
require general materno-fetal anesthesia. Standardized
protocols ensure both patient safety and technical success
[11, 12].
In contrast to previous assumptions, tocolytic require-
ments usually are minimal during the perioperative period
of most minimally invasive fetal interventions. Either no
tocolysis at all or only a one-time administration of either
indomethacin or nifedipin, sometimes accompanied by
infusion of the oxytocin antagonist atosiban, is used at our
center. Notably, in monochorionic twin gestations affected
by the twin-to-twin transfusion syndrome, indomethacin
may prompt dangerous degrees of ductus arteriosus con-
striction [13].
Patients requiring more intense tocolysis usually are the
ones who exhibit marked polyhydramnios resulting in
uterine contractions, abdominal pain, cervical shortening,
vaginal bleeding, and even increased C-reactive protein
levels before fetal intervention. Therefore, not surprisingly,
a massive polyhydramnios before fetal surgery accompa-
nied by the aforementioned signs and symptoms has been
the most important risk factor for perioperatively adverse
outcomes at our center.
Maternal and fetal safety
In contrast to open fetal surgery, the minimally invasive
fetoscopic approaches largely decrease maternal and fetal
morbidity. Nevertheless, despite the use of small-caliber
trocars, bleeding complications from vascular or placental
injuries, separation of chorioamniotic membranes, amni-
otic fluid leakage, chorioamnionitis, or early preterm
delivery must be expected to occur for some patients.
Nevertheless, the majority of fetuses undergoing fetoscopic
interventions, including those undergoing spina bifida
repair via three trocars, currently are born beyond
32 weeks of gestation. At this gestational age, the risks
from immaturity become so low that the benefits of the
prenatal intervention may outweigh its risks.
Intraamniotic access
Currently, most fetoscopic interventions can be performed
entirely by a percutaneous approach. Percutaneous intra-
amniotic access is facilitated by satisfactory ultrasound
image quality, a not too obese maternal abdominal wall,
and a favorable placenta position [14–16]. Depending on
the operative goal, one to three trocars are placed into the
amniotic cavity (Fig. 1). External trocar diameters usually
range from 3 to 5 mm.
Partial amniotic carbon dioxide insufflation
During complex fetoscopic surgical interventions, such as
those for spina bifida aperta that require tissue dissection
and resection, the amniotic fluid continuously gets tainted
by small amounts of blood. In this setting, only partial
Fig. 1 Typical operating room setup for fetoscopic surgery at the
author’s center. In this case, fetoscopic closure of fetal spina bifida
was performed, requiring a three-trocar approach
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insufflation of the amniotic cavity is needed to maintain
adequate visualization throughout the entire procedure
(Fig. 2).
Both technical and safety aspects of amniotic gas
insufflation have been examined in sheep and humans, with
conflicting safety results [15, 17–23]. Some investigators
observed that in this species, carbon dioxide insufflation
may result in fetal acidosis and demise. In contrast, our
group did not show detrimental effects of amniotic gas
insufflation with either compressed air or carbon dioxide
on the postnatal neurologic status, behavior, or brain his-
tology of sheep during fetoscopic interventions. Based on
our personal experience from these experiments, carbon
dioxide has become the insufflation medium of first choice
at our center.
At the time of this report, we had safely used partial
amniotic carbon dioxide insufflation (PACI) during 51
human fetoscopic surgical procedures, for which efforts at
obtaining sufficient visualization would have been too time
consuming or impossible with conventional means [24].
Nevertheless, because of this still very limited clinical
experience with PACI, continued assessment of its risks,
safety margins, and management issues accompanied by
serial postnatal patient follow-up evaluation using stan-
dardized development tests is desired.
Fetoscopic interventions
Diagnostic fetoscopy
The simplest fetoscopic procedures are diagnostic fetos-
copies. For example, a fetal muscle or skin biopsy can be
performed to rule out Duchenne muscular dystrophy or
Harlekin ichthyosis. These procedures usually are well
tolerated by the patient under maternal local anesthesia and
fetal analgo-sedation. At many centers, less invasive
ultrasound-guided biopsies have entirely replaced the
fetoscopic approach.
Fetoscopic laser coagulation in the treatment
of twin–twin transfusion syndrome
Severe twin–twin transfusion syndrome (TTTS) occurs in
about 10% of monochorionic twin gestations. Untreated,
the disease commonly results in the demise of both fetuses
[25]. Because monochorionic twins share a single placenta,
the circulation of one of the twins, the so-called ‘‘donor,’’
becomes compromised by blood and pressure loss via
arteriovenous anastomoses toward its sibling twin, the so-
called ‘‘recipient.’’ Additional venovenous or arterioarterial
anastomoses that modify the disease course and severity
also can be observed [26, 27].
On the other hand, the transfer of renin released by both
the hypotensive, hypovolemic donor and the placenta favor
the development of hypervolemia, hypertension, polyuria,
cardiac failure, and abnormal fetoplacental blood flow in
the recipient twin [28, 29]. Fetoscopic laser photocoagu-
lation of abnormal placental vessels in TTTS has been
developed and clinically introduced by de Lia et al. [4, 30]
(Fig. 3). With some modifications as to where the patho-
logic vessels should be targeted on the placental surface
[31], this approach has become the most commonly per-
formed and tested fetoscopic procedure worldwide.
The results of a randomized trial by the Eurofetus group
have proved that fetoscopic laser ablation is superior to
serial amnioreduction in improving outcome [32]. In short,
after fetoscopic laser ablation, the survival of at least one
Fig. 2 During complex fetoscopic surgical interventions such as
those for spina bifida aperta, only partial amniotic carbon dioxide
insufflation (PACI) can maintain adequate visualization throughout
the entire procedure. Top: Close-up view of instrument manipulations
using a 3.7-mm 308 fetoscope via three trocars with an external
diameter of 5 mm. Bottom left: Superior visibility offered by PACI
during dissection of the neural placode using a specially developed
microknife. Bottom right: After removal of pathologic tissues, the
neural tissue is covered by an absorbable patch
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twin can be expected in about 80% of cases and the sur-
vival of both twins in about half of cases. Most fetuses
currently are born beyond 30 weeks of gestation, and the
incidence of neurologic damage in survivors is low. Pre-
operative staging of affected fetuses is most commonly
performed by a system developed by Quintero et al. [33].
Based on a recent metaanalysis, fetoscopic laser ablation
may now be considered for treating all stages of TTTS
[34], yet further research investigating the effect of this
treatment on milder stages is recommended. The procedure
is performed with the patient under local anesthesia via a
single trocar or after direct insertion of the fetoscope shaft
using a stab trocar. For cases in which adequate visuali-
zation of an anterior placenta within blood-stained or turbid
amniotic fluid is difficult, PACI is used at our center [35].
At the end of the procedure, excess amniotic fluid is
drained, resulting in immediate improvement of maternal
discomfort.
Fetoscopic laser ablation of posterior urethral valves
Total bladder outlet obstruction by posterior urethral valves
before 20 weeks of gestation usually results in bilateral
kidney destruction and due to the concomitant lack of
amniotic fluid in severe pulmonary hypoplasia [36]. Pre-
natal intervention for this condition currently is most often
performed by ultrasound-guided percutaneous shunt
insertion for bladder drainage. Limited evidence from a
systematic review and metaananalysis suggests that this
approach may improve perinatal survival for affected
fetuses, particularly those with poor predicted prognoses
[37]. The University of Birmingham’s PLUTO (percuta-
neous shunting in lower urinary tract obstruction) trial aims
to provide more robust evidence by conducting a pro-
spective randomized multicenter investigation with a sub-
group of affected fetuses [38].
As an alternative to vesico-amniotic shunt insertion,
Quintero et al. [8] were the first to demonstrate the feasi-
bility of therapeutic fetal cystoscopy and endoscopic ful-
guration of posterior urethral valves. Since then, posterior
valve ablation has been performed by various groups for a
larger number of patients, albeit with limited success [39–
41]. Within the same anatomic region, endoscopic fetal
urethrotomy for anterior urethral valves also has been
described [42]. Recent technical modifications aim to
facilitate fetoscopic bladder entry and overcome access to
the proximal urethra from physiologic angulation of the
bladder neck [43].
Unfortunately, ultrasound examination and serial anal-
ysis of fetal urine samples before fetal intervention remain
unreliable for differentiating between groups of fetuses that
may or may not benefit from fetal intervention [44–47].
Therefore, further research is needed to improve fetal
selection for intervention and to perform it earlier in the
gestation period.
Fetoscopic lysis of amniotic bands
Amniotic bands constricting a fetal limb or the umbilical
cord may result in loss of extremity function or fetal
demise [48, 49]. After studies with fetal sheep demon-
strating the potential for functional recovery of affected
extremities after debanding [50], Quintero et al. [51] per-
formed the first fetoscopic lysis of amniotic bands in
human fetuses. Since then, the procedure has been per-
formed for small numbers of human fetuses with variable
success [52] (Fig. 4).
From our own limited experience with three fetuses, we
assume that Doppler ultrasound demonstration of both
Fig. 3 Fetoscopic laser photocoagulation of abnormal placental
vessels in twin–twin transfusion syndrome. The percutaneous proce-
dure is performed with the patient under local anesthesia via a single
trocar or after direct insertion of the fetoscope shaft. Most often, laser
ablation of pathologic vessels on the placental surface is performed
within amniotic fluid (top). For cases in which adequate visualization
of an anterior placenta within blood-stained or turbid amniotic fluid is
difficult, partial amniotic carbon dioxide insufflation (PACI) is used at
the author’s center (bottom)
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arterial and venous wave forms accompanied by active
muscle movements distal to the constriction indicate fetu-
ses with limb constriction that may benefit from band
removal [53].
Fetoscopic tracheal balloon occlusion in fetuses
with diaphragmatic hernia
Herniation of abdominal organs into the fetal chest results
in life-threatening pulmonary hypoplasia for about half of
prenatally detected fetuses with congenital diaphragmatic
hernia. Attempts at open fetal surgery to close the dia-
phragmatic defect during gestation did not improve sur-
vival for the most severely affected fetuses and impaired
outcome in the less severe cases [54]. Alternatively, the
therapeutic concept of fetoscopic tracheal occlusion was
developed and introduced clinically [55, 56].
After tracheal occlusion, the pressure buildup from fluid
normally released by the lung to maintain airway patency
and promote pulmonary development throughout gestation
results in lung distension and hyperplasia. Quintero et al.
[7] were the first to report percutaneous single-trocar
fetoscopic tracheal occlusion in a human fetus. Since then,
the technique has been refined further in animal studies
[57–59]. Like other single-trocar techniques, percutaneous
fetoscopic tracheal balloon occlusion can be performed
using maternal local anesthesia combined with fetal anal-
go-sedation and relaxation (Fig. 5). Fetal selection is based
on ultrasound assessment of liver position, the so-called
lung-to-head ratio, and/or determination of fetal lung vol-
ume by magnetic resonance imaging [60–62].
For awhile, the results of a National Institutes of Health
(NIH)-sponsored prospective randomized clinical trial
carried out at the University of California at San Francisco
(UCSF) stirred confusion about the value of the described
approach [63]. The trial was prematurely abandoned when
fetal tracheal occlusion had not improved outcome
Fig. 4 Amniotic bands constricting a fetal limb or the umbilical cord
may result in loss of extremity function or fetal demise. Top left:
Three-dimensional ultrasound image exhibiting severe constriction of
the distal third of the left calf in an unborn fetus at 21 ? 1 weeks of
gestation. Top right: Fetoscopic view during transection and removal
of the band in the gas-insufflated amniotic cavity. Bottom left:
Fetoscopic aspect after removal of the band. Pink skin coloration
distal to the obstruction site allows assumption of preserved
microvascular blood flow. Bottom right: After delivery, near normal
contour and function of the left foot were observed. (Color figure
online)
Fig. 5 Fetoscopic images during fetoscopic tracheal occlusion in a
late gestation fetus with severe diaphragmatic hernia. Fetoscopic view
using a 2-mm rod-lens endoscope in the fetal trachea before (top) and
after (bottom) balloon insertion
2060 Surg Endosc (2010) 24:2056–2067
123
compared with postnatal intensive care therapy offered in
this highly specialized center. Although obvious to the
specialist reader, most readers seemed to miss that the
study cohort included a marked proportion of less severely
affected fetuses and that early preterm premature delivery
also may have had an impact on the poor outcome in the
occlusion group.
Following an effective international recruitment strat-
egy, the Eurofetus consortium recently published their
sobering experience with fetoscopic tracheal balloon
occlusion in 210 cases with severe diaphragmatic hernia
[64]. In these fetuses, the group achieved survival rates of
49% for severely affected fetuses with left and 35% of
fetuses with right diaphragmatic hernia. Hinting to severe
logistical problems at the time of delivery, 10 deaths alone
could be directly attributed to difficulties with balloon
removal. In addition, following tracheal occlusion at a
mean gestational age of 27.1 weeks, 30% of cases where
born prior to 34 weeks. At this gestational age, poor out-
comes can be expected due to the more immature lungs and
because extracorporeal membrane oxygenation is usually
not an option.
Whereas Harrison et al. [63] already had speculated
from their trial that early preterm delivery after fetoscopic
tracheal occlusion might offset the beneficial effects of the
intervention on pulmonary growth and function, further
debate concerning the timing and duration of the occlusion
period ensued between the European groups [65, 66].
Based on the UCSF and the Eurofetus experience and the
ever growing body of experimental studies on fetal tracheal
occlusion, our group introduced the strategy of deliberately
delayed fetoscopic tracheal balloon occlusion [67]. The
first goal of this strategy was to prevent entirely iatrogenic
preterm delivery of immature fetuses with diaphragmatic
hernia by postponing the intervention to beyond 30 weeks
of gestation. The second goal was to achieve a gestational
age at delivery that enabled these frail infants to be pro-
vided all means of intensive care therapy, particularly
extracorporeal membrane oxygenation (ECMO). In addi-
tion, we reduced the occlusion period before removal of the
balloon again by fetoscopy to between 8 and 14 days. Yet
after application of our deliberately delayed and much
shorter fetoscopic tracheal occlusion approach in sixteen
fetuses with isolated left diaphragmatic hernia, only six
(37%) survived to discharge. Adding to the frustration, one
death resulted from anesthetic problems and three from
balloons dislodging within the first three days of treatment.
In these cases, two mothers opted against reintervention
and one for termination of pregnancy. Our recent efforts in
order to improve outcome in this subset of fetuses have
resulted in the development of a more reliable occlusion
device and in further postponing occlusion such that treated
fetuses are born even nearer to term.
As neither in the similar sized control group nor in the
failing-balloon group a single fetus with left diaphragmatic
hernia has survived despite the postnatal availability of
ECMO, I believe that the poor survival also reflects the
selection of severest cases. In contrast, we observed an
impressive survival rate in a small series of fetuses with
right diaphragmatic hernia undergoing temporary tracheal
occlusion at our center. Seven of eight fetuses (87%) with
isolated right diaphragmatic hernia survived postnatal
treatment to discharge. We attribute the markedly higher
survival rates following the delayed approach in right
diaphragmatic hernia to delivery of treated fetuses between
35 and 38 weeks of gestation, the regular availability of
extracorporeal membrane oxygenation (ECMO) on the first
day of life and despite smaller lungs to begin with the
intrinsic property of more normally developed pulmonary
vessels that vasodilate during materno-fetal hyperoxygen-
ation in the right-sided condition.
In the meantime, the deliberately delayed and shortened
approach to fetoscopic tracheal balloon occlusion has also
been adopted for a current randomized trial protocol by
Eurofetus, with the balloon placed at 30–32 ? 6 weeks of
gestation and removed at 34–35 ? 6 weeks of gestation
[68]. In our own randomized trial, we assess the value of the
delayed approach in relation to a variety of postnatal treat-
ment aspects for fetuses with less severe left diaphragmatic
hernia [69]. Despite the availability of similar data previ-
ously published by Eurofetus for much larger cohorts of
fetuses [70], an unblinded, nonrandomized trial by the pio-
neering fetal treatment center at UCSF simply focuses on
fetal lung growth after successful tracheal occlusion by serial
ultrasound assessment of the lung-to-head ratio [71].
Fetoscopic tracheal occlusion in fetuses with severe
pulmonary hypoplasia from early preterm premature
rupture of membranes
Early preterm premature rupture of membranes (ePPROM)
before 22 weeks of gestation affects thousands of pregnant
women throughout the world each year. Amniotic fluid loss
often is so severe that anhydramnios occurs. It is in these
cases that chronic external compression of the fetal chest
from the uterine wall and marked upward displacement of
the diaphragm by the liver interfere with normal lung
development. Pulmonary hypoplasia may become so
severe that chances of postnatal survival are poor [72].
Based on an analysis of 31 fetuses, Laudy et al. [73]
calculated a positive predictive value of 86% for the
development of lethal pulmonary hypoplasia when preterm
premature rupture of membranes occurred at or before
20 weeks of gestation followed by 8 weeks or more of
oligohydramnios and the degree of oligohydramnios was
1 cm or less.
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Experimental treatments such as the amniopatch pro-
cedure or serial amnioinfusions have been ineffective in
restoring adequate amounts of amniotic fluid in many
pregnancies with spontaneously occurring ePPROM [74–
76]. Therefore, based on the observation from ovine studies
that experimental fetal tracheal ligation prevents pulmon-
ary hypoplasia associated with fetal nephrectomy [77], we
performed percutaneous fetoscopic tracheal balloon
occlusion between 27 ? 6 and 28 ? 3 weeks of gestation
in three fetuses with severe fetal pulmonary compression/
hypoplasia from ePPROM [78, 79]. In each case, tracheal
occlusion resulted in stunningly fast improvements in lung
volume and survival.
Fetoscopic surgery for fetal laryngeal atresia
Near total to total occlusion of the fetal larynx or trachea is
rarely observed. In about half of fetuses, this malformation
occurs in association with Fraser syndrome [80]. Con-
comitant congestion of pulmonary fluid inside the fetal
tracheobronchial tree causes massive distension and
hyperplasia of the lungs as well as cardiac failure. For this
sequence of events, the telling acronym CHAOS (con-
genital high-airway obstruction syndrome) has been
coined. For affected hydropic fetuses, CHAOS has been
almost uniformly fatal, yet some have been salvaged by
elective preterm delivery using the ex utero intrapartum
(EXIT) procedure [81, 82].
In fetal sheep with iatrogenic CHAOS, prenatal
opening of the airway obstruction led to reversal of
hydropic changes [83]. Based on these findings and the
poor natural history of the syndrome, we performed
percutaneous fetoscopic tracheal decompression in two
hydropic human fetuses with laryngeal atresia and
CHAOS at about 20 weeks of gestation (Fig. 6) [9, 84].
Fetal cardiac filling, diaphragmatic function, lung hyper-
echogenicity, and the cardiothoracic area ratio progres-
sively normalized as a result of the percutaneous
fetoscopic intervention. Both infants survived to dis-
charge from the hospital.
Fetoscopic spina bifida repair
Fetal surgery on unborns with spina bifida aims to protect
the exposed neural tissue from amniotic fluid, fetal stool,
and mechanical stress and to reduce hindbrain herniation
[85, 86]. After studies with sheep, the first fetoscopic
approaches for spina bifida closure in humans by maternal
laparotomy, uterine exteriorization, and transuterine trocar
placement were reported in the United States by Bruner
et al. and Farmer et al. [23, 87–89]. Yet both teams
abandoned their fetoscopic approaches because early
results were disappointing due to technical difficulties.
Since then, fetoscopic fetal surgery for spina bifida has
been replaced by an open surgical approach performed
currently for several hundreds of human fetuses in North
America [89, 90] and also for some fetuses in Brazil,
Poland, and Spain. Pending the results of a randomized trial
(MOMS trial), the therapeutic potential of the open opera-
tion to improve leg, bladder, and bowel function and to
reduce the severity of hindbrain malformation and hydro-
cephalus will remain controversially discussed [91–100].
To minimize maternal trauma from the open fetal surgical
approach, after technical feasibility studies with inanimate
models and sheep, our group reintroduced a percutaneous
minimally invasive fetoscopic approach [10, 101]. Currently,
the approach allows precise dissection of the placode, resec-
tion of pathologic tissues, and coverage of the malformation
in layers such that neonatal neurosurgical repair currently has
been obviated in already 10 cases (Fig. 2) [102, 103].
Probably because of more careful attention to membrane
closure at the time of trocar removal than in earlier patients
[104], most surgically treated fetuses currently are deliv-
ered at 32–35 weeks of gestation. From our early clinical
experience in 25 human fetuses it appears that
Fig. 6 Sonographic and fetoscopic findings in a human fetus with
congenital high-airway obstruction syndrome (CHAOS) from lar-
yngeal atresia at 21 ? 3 weeks of gestation. Top left: Fetal ultrasound
imaging in the four-chamber view depicts the typical findings of
bilateral lung hyperechogenicity and enlargement as well as a small
heart. Top right: Five days after fetoscopic tracheal decompression,
improvement in fetal heart–lung size relationship and normalization
of lung echogenicity can be observed. Bottom left: Fetal laryngoscopy
using a 2-mm 0 rod-lens fetoscope confirms laryngeal atresia by a
membrane seen beneath the vocal folds. Bottom right: To achieve
fetal tracheal decompression, a laser fiber was advanced via the
working channel of the fetoscope and placed above the atretic region.
At this location, the fiber was activated and repositioned until four
small 0.4-mm openings were achieved
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1. the quality of leg function (and also likely bladder and
bowel function), present at the time of surgery can be
preserved in these fetuses, regardless of lesion height,
2. the fetoscopic procedure reliably results in improve-
ments of hindbrain herniation, and
3. progressive ventricular dilatation and postnatal ventri-
culo-peritoneal shunt insertion can be avoided in most
cases when the lateral ventricular width is B 12 mm at
the time of surgery.
Fetal cardiac interventions assisted by fetoscopy
Fetal cardiac interventions are being developed to improve
the outcome and prognosis of fetuses with a spectrum of
cardiac malformations, most often severe semilunar valve
obstructions [110]. During fetal balloon valvuloplasty, we
found that fetoscopic fetal transesophageal echocardiogra-
phy (FFTEE) permits substantially clearer definition of
fetal cardiac anatomy and intracardiac device manipulation
than conventional maternal transabdominal fetal echocar-
diography (Fig. 7) [105–108].
Most recently, fetoscopic transesophageal electrocardi-
ography has become available a minimally invasive tool
for cardiac monitoring, diagnostics and intervention in
human fetuses with theray refractory fetal tachycardias
[109].
Less invasive alternatives to other fetoscopic
procedures
Fetoscopic procedures such as umbilical cord ligation
(Fig. 8) in discordant monochorionic twins or in the twin-
reversed arterial perfusion (TRAP) sequence will most
likely be replaced by technically far more simple and less
invasive percutaneous ultrasound guided radiofrequency
ablation of the umbilical vessels [110].
Fig. 7 Fetoscopic fetal transesophageal echocardiography (FFTEE)
at 26 ? 6 weeks of gestation in a human fetus with a closed atrial
septum and aortic atresia. Top: Ultrasound catheter insertion requiring
a single trocar. Middle: The closed atrial septum and the hypoplastic
aortic root can be identified clearly (LA, left atrium; RA, right
atrium). Bottom: A microinstrument with opened jaw (arrow) can be
seen directed against the septum. Such clear demonstration of an
intracardiac interventional device usually is not possible with the
conventional imaging approach
Fig. 8 Fetoscopic umbilical cord ligation in a discordant monocho-
rionic twin pregnancy via a single trocar. Top: External aspect during
knot pushing. Bottom: Clear demonstration of umbilical cord,
ligature, and knot pusher during cord ligation in the gas insufflated
amniotic cavity
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Conclusion
For an increasing spectrum of fetal malformations and
disease states, minimally invasive fetoscopic techniques
can now be offered. Nevertheless, because these proce-
dures still rely heavily on equipment borrowed from other
specialties, further development of specialized instrumen-
tation and devices is required. Their efficacy for improving
fetal outcome over that demonstrated by state-of-the-art
postnatal treatment strategies requires further studies in
dedicated centers.
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